Page last updated: 2024-08-25

6-amino-1-hydroxyhexane-1,1-diphosphonate and Breast Cancer

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chebbi, I; Lecouvey, M; Migianu-Griffoni, E; Sainte-Catherine, O; Seksek, O1
Bareggi, R; Narducci, P; Nicolin, V1

Other Studies

2 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Breast Cancer

ArticleYear
In vitro assessment of liposomal neridronate on MDA-MB-231 human breast cancer cells.
    International journal of pharmaceutics, 2010, Jan-04, Volume: 383, Issue:1-2

    Topics: Breast Neoplasms; Caco-2 Cells; Capsules; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diphosphonates; Female; Humans; Liposomes; Matrix Metalloproteinases

2010
Role of neridronate on MCF-7 estrogen dependent breast cancer model of bone metastasis: a preliminary study.
    Investigational new drugs, 2011, Volume: 29, Issue:1

    Topics: Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Densitometry; Diphosphonates; Estrogens; Female; Humans; Models, Biological; Neoplasms, Hormone-Dependent; RANK Ligand

2011